BioSpace News Archive

PDL BioPharma, Inc. (“PDL” or the “Company”) (Nasdaq: PDLI) today announced the resignation of Chief Financial Officer, Peter Garcia, who will be leaving the Company effective August 15, 2019.

Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer, today announced that it has commenced an underwritten public offering of approximately $100 million of shares of its common stock.

The transaction is subject to regulatory review and anticipated to close before the end of 2019.

VivaLNK, a leading provider of connected healthcare solutions, announces today the results of a survey that paints a clear picture of what drives today’s patients to adopt health wearables

Vycellix™, Inc. today announced that the Company, founded by leading medical researchers at Sweden’s world renowned Karolinska Institutet, has appointed the inaugural members of its Scientific Advisory Board (SAB).

Centauri Health Solutions Co-Founder and CEO Adam Miller has been selected as the EY Entrepreneur Of The Year® 2019 Award winner in the Healthcare category for the Mountain Desert Region, encompassing Arizona, Colorado and New Mexico.

Program will train policy makers how to regulate growing industry

Joseph Tarantino, president and CEO of global consulting firm Protiviti, and Brian Christensen, executive vice president and global leader of Protiviti’s internal audit and financial advisory practice, have both been named to the NACD (National Association of Corporate Directors) 2019 Directorship 100™ list.

The Feinstein Institutes for Medical Research hosted a Match Lecture by 2014 Nobel Laureate in Physiology or Medicine John O’Keefe, MA, PhD, who discussed the idea that the hippocampus is a cognitive map.

The National Organization for Rare Disorders® (NORD), the leading independent nonprofit organization representing the 25-30 million Americans living with rare diseases, has announced ten new grants as part of its Rare Disease Research Grant Program, which celebrates its 30th anniversary in 2019.